Climb Bio, Inc.
NASDAQ:CLYMBiotechnology
Healthcare
$9.78 +0.17%
+$0.02 today
- Market cap
- $574.46M
- Beta
- 0.10
- P/E (TTM)
- -14.7
- EPS (TTM)
- -$0.77
52W Low $1.17High $12.48
Volume 0.59M
Average 0.88M
Price history
Climb Bio, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
+412.04%
Period high
$17.84
Period low
$1.64
Latest
$9.78
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| SC 13D/A | Nov 9, 2026 | Nov 9, 2026 | |
| SC 13G/A | Nov 5, 2026 | Nov 5, 2026 | |
| S-3ASR | Nov 5, 2026 | Nov 5, 2026 | |
| 10-Q | Nov 5, 2026 | Nov 5, 2026 | |
| 8-K | Nov 5, 2026 | Nov 5, 2026 | |
| SC 13G | Oct 28, 2026 | Oct 28, 2026 | |
| SC 13G | Oct 27, 2026 | Oct 27, 2026 | |
| 8-K | Oct 26, 2026 | Oct 26, 2026 | |
| 8-K | Oct 23, 2026 | Oct 23, 2026 |
Competitors
Who does Climb Bio, Inc. compete with?
Open similar companies to compare their filings and price history.
Questions
Filing questions
Common questions about CLYM's filings, answered from its disclosures.
What is the latest CLYM filing?
The latest filing shown is SC 13D/A dated Nov 9, 2026.
How many recent filings does CLYM have?
Intrinsic Alpha currently shows 9 recent filings for CLYM.
Continue the stock analysis
Jump to another research area for this company.